Hospital
Hannibal Regional Healthcare System, INC
Hannibal Regional Healthcare System, INC was paid $14.43M by Medicaid between Jan 2018 and Dec 2024, across 95 billing codes. Its largest line is Y7506, — 16% of everything it billed.
33Billing provider infoHANNIBAL REGIONAL HEALTHCARE SYSTEM, INC
HANNIBAL, MO 63401
HANNIBAL, MO 63401
33aNPI1922042704assigned 06/15/2006
33bProvider typeRural Acute Care Hospital
28Total paid$14.43M
24GClaims201,727
24DCodes billed95
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,297 | $3.17M | |
| 2019 | 17,720 | $3.56M | |
| 2020 | 16,028 | $1.84M | |
| 2021 | 28,010 | $753K | |
| 2022 | 37,465 | $1.35M | |
| 2023 | 47,055 | $2.05M | |
| 2024incomplete | 40,152 | $1.71M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Y7506 | 16% | 6,882 | 6,437 | $2.25M | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 12,170 | 11,064 | $2.21M |
| X4011 | State-specific procedure code | 9.4% | 8,052 | 7,413 | $1.36M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.5% | 9,578 | 9,029 | $1.23M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.9% | 22,323 | 20,038 | $1.14M |
| 80053 | Comprehensive metabolic panel | 7.3% | 19,647 | 17,853 | $1.05M |
| Y7507 | 4.2% | 1,495 | 1,387 | $613K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.6% | 4,836 | 4,347 | $518K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.2% | 10,838 | 9,600 | $468K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 5,194 | 4,955 | $385K |
| 71045 | Radiologic examination, chest; single view | 2.3% | 6,430 | 5,819 | $332K |
| 81001 | 1.8% | 7,623 | 7,056 | $264K |
83 more codes
| 83690 | 1.7% | 5,638 | $247K | |
| 84703 | 1.7% | 4,251 | $242K | |
| 82803 | 1.1% | 3,344 | $165K | |
| 84484 | <1% | 7,231 | $136K | |
| 99285 | Emergency room visit (most serious) | <1% | 373 | $133K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,256 | $120K |
| 83735 | <1% | 6,523 | $114K | |
| 85610 | <1% | 5,479 | $114K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 533 | $111K |
| 87400 | <1% | 743 | $96K | |
| 82150 | <1% | 871 | $88K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,680 | $87K |
| 81003 | <1% | 1,692 | $86K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,151 | $80K |
| J3490 | Unclassified drugs | <1% | 5,789 | $71K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,033 | $69K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 5,678 | $69K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,440 | $56K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,362 | $52K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,783 | $42K |
| 83880 | <1% | 1,710 | $41K | |
| X4006 | <1% | 52 | $40K | |
| 87428 | <1% | 1,685 | $34K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 587 | $25K |
| 62323 | <1% | 101 | $22K | |
| 87807 | <1% | 273 | $22K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 221 | $21K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 56 | $19K |
| 83605 | <1% | 2,315 | $16K | |
| 84145 | <1% | 1,153 | $15K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $14K |
| 80306 | <1% | 534 | $14K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,879 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 239 | $11K |
| 87070 | <1% | 695 | $11K | |
| 87040 | <1% | 216 | $9K | |
| 86900 | <1% | 114 | $8K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 130 | $8K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 141 | $7K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 390 | $6K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 283 | $6K |
| 87186 | <1% | 60 | $5K | |
| 82077 | <1% | 564 | $5K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 101 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 613 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 415 | $4K |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 605 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 82 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 83 | $4K |
| 85027 | <1% | 884 | $4K | |
| 86850 | <1% | 117 | $4K | |
| 87205 | <1% | 14 | $3K | |
| 80061 | Lipid panel | <1% | 237 | $2K |
| 86901 | <1% | 114 | $2K | |
| 80164 | <1% | 218 | $2K | |
| 85730 | <1% | 849 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 84 | $2K |
| 82962 | <1% | 102 | $2K | |
| 82550 | <1% | 14 | $2K | |
| 82553 | <1% | 12 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $1K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 15 | $1K |
| 83655 | <1% | 101 | $806.27 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 38 | $638.46 |
| 85379 | <1% | 107 | $485.12 | |
| 80143 | <1% | 29 | $360.39 | |
| 80179 | <1% | 30 | $360.39 | |
| 86780 | <1% | 26 | $327.32 | |
| 94060 | <1% | 12 | $306.96 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 97 | $306.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 28 | $280.00 |
| 71250 | <1% | 12 | $266.93 | |
| 86803 | <1% | 25 | $198.76 | |
| 84480 | <1% | 14 | $159.50 | |
| 86141 | <1% | 12 | $128.17 | |
| 84436 | <1% | 14 | $77.25 | |
| 85018 | <1% | 46 | $64.44 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 152 | $51.02 |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 29 | $16.32 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | $2.10 |
| 94726 | 0% | 12 | $0.00 | |
| 59025 | Fetal non-stress test | 0% | 17 | $0.00 |
| 94729 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDIX, ROGER (CFO)
| Provider | Location | Paid |
|---|---|---|
| Hannibal Regional Healthcare System INC | Louisiana, MO | $268K |
| Hannibal Regional Healthcare System, INC | Monroe City, MO | $175K |
| Hannibal Regional Healthcare System, INC | Shelbina, MO | $146K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.